Recurrent Bioprosthetic Valve Serratia marcescens Endocarditis in Intravenous Drug Users
American Journal of Case Reports · 2023
DOI: 10.12659/ajcr.939292 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Case Reports, 2023. Verfasst von Dana Sadaqa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Birzeit University, Birzeit, Palestinian Territory, Occupied. Hauptthemen laut MEDLINE: Drug Users, Substance Abuse, Intravenous, Endocarditis, Endocarditis, Bacterial. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Birzeit University, Birzeit, Palestinian Territory, Occupied.
- Department of Internal Medicine, Marshall University School of Medicine, Huntington, WV, USA.
- Department of Internal Medicine, Hadassah University Hospital, Mount Scopus, Jerusalem, Israel.
ORCID-Profile: Hamza M Alsaid
Zitieren
APA
Sadaqa, D., Daoud, A., Zeid, F., & Alsaid, H. M. (2023). Recurrent Bioprosthetic Valve Serratia marcescens Endocarditis in Intravenous Drug Users. American Journal of Case Reports. https://doi.org/10.12659/ajcr.939292
Vancouver
Sadaqa D, Daoud A, Zeid F, Alsaid HM. Recurrent Bioprosthetic Valve Serratia marcescens Endocarditis in Intravenous Drug Users. American Journal of Case Reports. 2023. doi:10.12659/ajcr.939292
BibTeX
@article{Sadaqa2023,
author = {Sadaqa, Dana and Daoud, Amro and Zeid, Fuad and Alsaid, Hamza M},
title = {Recurrent Bioprosthetic Valve Serratia marcescens Endocarditis in Intravenous Drug Users},
journal = {American Journal of Case Reports},
year = {2023},
doi = {10.12659/ajcr.939292}
}
EUVIMED